$Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma$

Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma

Craig, Michael; Hanna, Wahid T.; Cabanillas, Fernando; Chen, Chien-Shing; Esseltine, Dixie-Lee; Neuwirth, Rachel; O'Connor, Owen A.

期刊名称British Journal of Haematology
作者Craig, Michael; Hanna, Wahid T.; Cabanillas, Fernando; Chen, Chien-Shing; Esseltine, Dixie-Lee; Neuwirth, Rachel; O'Connor, Owen A.
卷第166卷
期第6期
印刷ISSN0007-1048
文件大小119.79KB
发表时间2014-09
DOI10.1111/bjh.12991
页码920-928

发现好书期刊，享受阅读乐趣

Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma